SEC Filing Details

Document Details

Filing Date
Nov 14, 2022
Document Date
Nov 14, 2022
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
Acrivon Therapeutics, Inc.
Issuer
ACRIVON THERAPEUTICS, INC.